![]() |
市場調查報告書
商品編碼
2058701
個人化膳食補充劑市場預測至2034年-按產品類型、個人化方法、劑型、通路和最終用戶分類的全球分析Personalized Nutrition Supplements Market Forecasts to 2034 - Global Analysis By Product Type, Personalization Approach, Form Type, Distribution Channel, and End User |
||||||
根據 Stratistics MRC 的數據,全球個人化營養補充劑市場預計將在 2026 年達到 177 億美元,並在預測期內以 18.1% 的複合年成長率成長,到 2034 年達到 670 億美元。
個人化營養補充品根據個人的遺傳、生活方式、飲食和健康目標等因素,量身定做,以滿足其健康需求。這些產品利用數據分析、人工智慧和診斷工具,創造個人化的補充方案。其目標是透過解決特定的營養缺乏和健康目標,最佳化健康狀況。消費者對個人化醫療保健和精準營養日益成長的需求正在推動市場成長。科技和健康數據的進步使得更精準、更便利的個人化客製化成為可能。
擴大健康數據追蹤
科學研究強調了腸道菌叢在消化和免疫中的重要作用,從而推動了對有益於腸道健康和消化器官系統健康的食品的需求。人們積極尋找能夠平衡消化功能的產品。宣傳宣傳活動正在提高消費者對益生菌和益生元的認知。機能性食品在日常飲食中的重要性日益凸顯。隨著人們意識的提高,市場需求持續穩定成長。
用戶對資料隱私的擔憂
益生菌產品需要精心儲存以維持活菌的存活率。溫度敏感度會影響產品的功效。不當的儲存條件可能會降低其健康益處。這給運輸和零售環節帶來了挑戰。消費者在家中也可能難以維持適當的儲存條件。保存期限限制也增加了生產商的複雜性。這些因素可能會限制市場成長。
人工智慧營養推薦平台
益生元和合合益素產品的創新正在為市場創造新的機會。消費者正在尋找能夠對消化器官系統產生多方面影響的產品。合益素配方可以增強益生菌的功效。各公司正在開發穩定性更高的先進產品。研究也證實了有益腸道成分的益處。新的產品形態正吸引消費者的目光。預計這一趨勢將帶來強勁的成長機會。
個性化模型準確性的局限性
某些產品可能不含標籤上標示的菌株或數量,這會降低消費者信心和產品可靠性。缺乏嚴格的監管標準增加了資訊誤導的風險,消費者可能無法獲得預期的健康益處。品牌必須確保標籤準確透明。這些問題可能會對市場成長產生負面影響。
疫情期間,消費者對免疫力和消化健康的關注度顯著提升,益生菌和腸道健康產品的需求激增。消費者開始青睞具有增強免疫功能的機能性食品。線上通路在產品分銷中發揮了至關重要的作用。各大品牌紛紛拓展產品線以滿足不斷成長的需求。初期,供應鏈中斷影響了生產。整體而言,疫情期間及之後,市場均呈現強勁成長態勢。
在預測期內,膠囊和片劑細分市場預計將佔據最大的市場佔有率。
預計在預測期內,膠囊和片劑產品將佔據最大的市場佔有率。這主要歸功於消費者為了維持消化系統健康而廣泛食用優格、發酵食品和機能飲料。在許多地區,這些產品已成為日常飲食習慣的一部分。許多消費者更傾向於選擇源自天然食品的益生菌,而非膳食補充劑。消費者對消化系統健康的日益重視正在推動產品的普及。零售通路的廣泛覆蓋也促進了市場需求。持續的產品創新正在不斷提升產品的口感和使用便利性。
在預測期內,基於微生物組的營養細分市場預計將呈現最高的複合年成長率。
在預測期內,由於消費者對預防醫學和免疫功能增強的興趣日益濃厚,基於微生物組的營養品領域預計將呈現最高的成長率。腸道環境與免疫功能有密切關係。消費者正在選擇能夠同時增強消化和免疫力的產品。對具有額外健康益處的機能性食品的需求正在成長。生活方式的改變正在促進更健康的飲食習慣。各大品牌紛紛推出聲稱能夠改善免疫功能的產品。
在預測期內,北美預計將佔據最大的市場佔有率。這主要得益於美國和加拿大消費者對益生菌產品的強勁需求,而這種需求又受到人們對腸道健康和機能性食品日益成長的關注的推動。消費者正積極地將有益腸道的食品融入日常飲食中。主要廠商的存在也為市場成長提供了支持。先進的零售和線上通路提高了產品的可近性。產品創新也提升了消費者的興趣。較高的購買力進一步促進了產品的普及。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度、日本和韓國等國家悠久的發酵食品消費傳統,以及人們對消化健康日益成長的關注。人口成長推動了產品需求的擴大。都市化正在影響人們的飲食結構,使其更加重視機能性食品。零售和電商平台的擴張提高了產品的可近性。本土品牌正在拓展產品線。人們對健康和保健的日益關注也促進了市場成長。
According to Stratistics MRC, the Global Personalized Nutrition Supplements Market is accounted for $17.7 billion in 2026 and is expected to reach $67.0 billion by 2034 growing at a CAGR of 18.1% during the forecast period. Personalized Nutrition Supplements are tailored to individual health needs based on factors such as genetics, lifestyle, diet, and health goals. These products use data analytics, AI, and diagnostic tools to create customized supplement plans. They aim to optimize health outcomes by addressing specific nutritional deficiencies and wellness goals. Increasing consumer demand for personalized healthcare and precision nutrition is driving growth. Advances in technology and health data are enabling more accurate and accessible customization.
Growth in health data tracking
Scientific research is highlighting the role of the microbiome in digestion and immunity. This is driving demand for gut health and digestive wellness foods. People are actively seeking products that support digestive balance. Awareness campaigns are improving consumer understanding of probiotics and prebiotics. Functional foods are gaining importance in daily diets. As awareness grows, market demand continues to expand steadily.
Data privacy concerns among users
Probiotic products require careful storage to maintain the viability of live cultures. Temperature sensitivity can affect product effectiveness. Improper storage conditions may reduce health benefits. This creates challenges in transportation and retail handling. Consumers may also face difficulties in maintaining correct storage at home. Shelf-life limitations add to the complexity for manufacturers. These factors can restrict market growth.
AI-driven nutrition recommendation platforms
Innovation in prebiotic and synbiotic products is creating new opportunities in the market. Consumers are seeking products that offer combined digestive benefits. Synbiotic formulations enhance the effectiveness of probiotics. Companies are developing advanced products with improved stability. Research is supporting the benefits of gut-friendly ingredients. New product formats are increasing consumer appeal. This trend is expected to create strong growth opportunities.
Limited accuracy of personalization models
Some products may not contain the claimed strains or quantities. This reduces consumer trust and product credibility. Lack of strict regulatory standards increases the risk of misinformation. Consumers may not achieve expected health benefits. Brands must ensure accurate labeling and transparency. These issues can negatively impact market growth.
The pandemic increased consumer focus on immunity and digestive health. Demand for probiotic and gut health products rose significantly. Consumers preferred functional foods that support immune function. Online channels became important for product distribution. Brands expanded their offerings to meet increased demand. Supply chain disruptions affected production in early stages. Overall, the market experienced strong growth during and after the pandemic.
The capsules & tablets segment is expected to be the largest during the forecast period
The capsules & tablets segment is expected to account for the largest market share during the forecast period as consumers widely consume yogurt, fermented foods, and functional beverages for digestive health support. These products are part of regular dietary habits in many regions. Natural food-based probiotics are preferred over supplements by many consumers. Increasing awareness of digestive health supports adoption. Wide availability across retail channels boosts demand. Continuous product innovation is improving taste and convenience.
The microbiome-based nutrition segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbiome-based nutrition segment is predicted to witness the highest growth rate due to increasing focus on preventive healthcare and immune system support among consumers. Gut health is closely linked with immune function. Consumers are choosing products that enhance both digestion and immunity. Demand is rising for functional foods with added health benefits. Lifestyle changes are encouraging healthier eating habits. Brands are launching products with targeted immunity claims.
During the forecast period, the North America region is expected to hold the largest market share owing to high awareness of gut health and functional foods in the United States and Canada supported by strong consumer demand for probiotic products. Consumers actively include gut-friendly foods in their daily diets. Presence of leading food and beverage companies supports market growth. Advanced retail and online channels improve accessibility. Product innovation is also driving consumer interest. High spending capacity further boosts adoption.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by strong tradition of consuming fermented foods in countries such as China, India, Japan, and South Korea along with rising awareness of digestive health. Growing population is supporting higher product demand. Urbanization is influencing dietary habits toward functional foods. Expansion of retail and e-commerce platforms improves product availability. Local brands are expanding their product offerings. Increasing focus on health and wellness supports growth.
Key players in the market
Some of the key players in Personalized Nutrition Supplements Market include Nestle Health Science, Abbott Laboratories, Amway Corporation, Herbalife Nutrition Ltd., Bayer, Bioniq, Persona Nutrition, Rootine, Gainful, Viome Life Sciences, Habit LLC, Nutrafol, Glanbia plc, Now Health Group and Thorne HealthTech.
In March 2026, Herbalife announced a definitive agreement to acquire certain assets from Bioniq, a UK-based personalized supplement company, for a total potential value of $150 million. This partnership-led transaction integrates Bioniq's patented biomarker-based personalization engine with Herbalife's global distributor network to scale data-driven wellness across the U.S. and Europe.
In November 2025, Abbott entered into a merger agreement to acquire Exact Sciences for approximately $48.7 billion to lead the convergence of diagnostics and personalized nutrition. This collaboration, which reached a significant integration milestone in early 2026, combines advanced cancer and metabolic screening technology with Abbott's global nutritional portfolio to offer a more proactive, "diagnostic-first" approach to longevity.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.